Channelopathies: the Nondystrophic Myotonias and Periodic Paralyses
Overview
Pediatrics
Authors
Affiliations
The term channelopathy does not indicate a new group of neuromuscular conditions, but a re-orientation of well- and long-known muscular conditions, the congenital myotonias, and the periodic paralyses. Although, in the past, they have overlapped clinically here and there, both groups were classified differently, as myotonias and as metabolic myopathies, respectively. The discovery of mutations in several ion channels has rewritten nosography of these disorders and procured a new term, the channelopathy-clinical, electrophysiological, and molecular genetic details of which are discussed in this chapter.
Yi H, Liu C, Ye S, Liu Y World J Clin Cases. 2024; 12(3):587-595.
PMID: 38322461 PMC: 10841953. DOI: 10.12998/wjcc.v12.i3.587.
Skeletal Muscle Channelopathies.
Phillips L, Trivedi J Neurotherapeutics. 2018; 15(4):954-965.
PMID: 30341599 PMC: 6277285. DOI: 10.1007/s13311-018-00678-0.
Treatment and management of neuromuscular channelopathies.
Sharp L, Trivedi J Curr Treat Options Neurol. 2014; 16(10):313.
PMID: 25118992 DOI: 10.1007/s11940-014-0313-6.
Nondystrophic myotonia: challenges and future directions.
Trivedi J, Cannon S, Griggs R Exp Neurol. 2013; 253:28-30.
PMID: 24361411 PMC: 4078724. DOI: 10.1016/j.expneurol.2013.12.005.
Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.
Trivedi J, Bundy B, Statland J, Salajegheh M, Raja Rayan D, Venance S Brain. 2013; 136(Pt 7):2189-200.
PMID: 23771340 PMC: 3692030. DOI: 10.1093/brain/awt133.